Exact Mass: 656.3421118
Exact Mass Matches: 656.3421118
Found 34 metabolites which its exact mass value is equals to given mass value 656.3421118,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
(2R)-2-[[(2R)-2-[[(2S)-2-(Azepane-1-carbonylamino)-4-methylpentanoyl]amino]-3-(1-formylindol-3-yl)propanoyl]amino]-3-(1H-indol-3-yl)propanoic acid
C36H44N6O6 (656.3322164000001)
PREGN-5-EN-20-ONE,3-[(6-O-B-D-GLUCOPYRANOSYL-B-D-GLUCOPYRANOSYL)OXY]-14-HYDROXY-,(3B,14B)- (9CI)
2alpha,3beta-dihydroxy-5alpha-pregn-16-en-20-one-3-O-beta-D-glucopyranosyl(1->4)-beta-D-galactopyranoside
Arg Arg Tyr Tyr
Arg Tyr Arg Tyr
Arg Tyr Tyr Arg
Tyr Arg Arg Tyr
Tyr Arg Tyr Arg
Tyr Tyr Arg Arg
Deferoxamine mesylate
D064449 - Sequestering Agents > D002614 - Chelating Agents > D007502 - Iron Chelating Agents COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS Deferoxamine mesylate (Deferoxamine B mesylate) is an iron chelator (binds to Fe(III) and many other metal cations), is widely used to reduce iron accumulation and deposition in tissues. Deferoxamine mesylate upregulates HIF-1α levels with good antioxidant activity. Deferoxamine mesylate also shows anti-proliferative activity, can induce apoptosis and autophagy in cancer cells. Deferoxamine mesylate can be used in studies of diabetes, neurodegenerative diseases as well as anti-cancer and anti-COVID-19[1][2][3][4][5].
(2E,4S,5S,6R,7R,8R,9R,10R,11S,12R,13Z,15E)-5,7,9,11-tetrahydroxy-17-[(6-hydroxy-3,7-dimethyl-1,4-dioxo-5,8-dihydronaphthalen-2-yl)amino]-2,4,6,8,10,12,16-heptamethyl-17-oxoheptadeca-2,13,15-trienoate
C36H50NO10- (656.3434540000001)
N-{5-[acetyl(hydroxy)amino]pentyl}-N-(5-{4-[(5-aminopentyl)(hydroxy)amino]-4-oxobutanamido}pentyl)-N-hydroxybutanediamide methanesulfonate
D064449 - Sequestering Agents > D002614 - Chelating Agents > D007502 - Iron Chelating Agents